DaVita Inventory 2010-2025 | DVA

DaVita inventory from 2010 to 2025. Inventory can be defined as the total value of inventories in all stages of completion.
  • DaVita inventory for the quarter ending March 31, 2025 was $0.151B, a 3.23% increase year-over-year.
  • DaVita inventory for 2024 was $0.135B, a 5.97% decline from 2023.
  • DaVita inventory for 2023 was $0.143B, a 31.14% increase from 2022.
  • DaVita inventory for 2022 was $0.109B, a 1.58% increase from 2021.
DaVita Annual Inventory
(Millions of US $)
2024 $135
2023 $143
2022 $109
2021 $107
2020 $112
2019 $98
2018 $107
2017 $182
2016 $160
2015 $186
2014 $136
2013 $89
2012 $78
2011 $76
2010 $76
2009 $70
DaVita Quarterly Inventory
(Millions of US $)
2025-03-31 $151
2024-12-31 $135
2024-09-30 $129
2024-06-30 $127
2024-03-31 $146
2023-12-31 $143
2023-09-30 $110
2023-06-30 $110
2023-03-31 $107
2022-12-31 $109
2022-09-30 $107
2022-06-30 $110
2022-03-31 $108
2021-12-31 $107
2021-09-30 $114
2021-06-30 $115
2021-03-31 $116
2020-12-31 $112
2020-09-30 $106
2020-06-30 $98
2020-03-31 $96
2019-12-31 $98
2019-09-30 $99
2019-06-30 $97
2019-03-31 $104
2018-12-31 $107
2018-09-30 $91
2018-06-30 $113
2018-03-31 $126
2017-12-31 $182
2017-09-30 $154
2017-06-30 $199
2017-03-31 $174
2016-12-31 $160
2016-09-30 $201
2016-06-30 $197
2016-03-31 $193
2015-12-31 $186
2015-09-30 $173
2015-06-30 $159
2015-03-31 $146
2014-12-31 $136
2014-09-30 $115
2014-06-30 $100
2014-03-31 $101
2013-12-31 $89
2013-09-30 $85
2013-06-30 $78
2013-03-31 $77
2012-12-31 $78
2012-09-30 $78
2012-06-30 $78
2012-03-31 $72
2011-12-31 $76
2011-09-30 $73
2011-06-30 $69
2011-03-31 $70
2010-12-31 $76
2010-09-30 $69
2010-06-30 $69
2010-03-31 $68
2009-12-31 $70
2009-09-30 $69
2009-06-30 $65
2009-03-31 $71
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $10.458B $12.816B
DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services. DaVita's Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis services, routine laboratory testing for ESRD patients and management services to outpatient dialysis centers. The company's other ancillary services and strategic initiatives segment includes its international dialysis services, pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $18.936B 18.66
Encompass Health (EHC) United States $11.956B 25.34
Chemed (CHE) United States $8.214B 25.81
Elanco Animal Health (ELAN) United States $6.293B 13.48
Option Care Health (OPCH) United States $5.245B 23.38
RadNet (RDNT) United States $4.259B 270.33
Amedisys (AMED) United States $3.071B 20.65
LifeStance Health (LFST) United States $2.189B 0.00
Addus HomeCare (ADUS) United States $2.052B 22.53
Astrana Health (ASTH) United States $1.372B 33.99
U.S Physical Therapy (USPH) United States $1.145B 29.57
Aveanna Healthcare Holdings (AVAH) United States $1.044B 59.44
Pennant (PNTG) United States $0.967B 35.52
Atai Life Sciences (ATAI) Germany $0.405B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.045B 0.00
Daxor (DXR) United States $0.039B 0.00
Ontrak (OTRK) United States $0.007B 0.00
Psychemedics (PMD) United States $0.000B 0.00